Study supports the role of PSMA PET for risk stratifying patients with clinically node-positive disease before radical prostatectomy, along with mpMRI and clinical parameters.
Surrogate endpoints can substantially shorten clinical trials and expedite approvals of new drugs, but they are elusive and sometimes controversial.
Significant reductions seen in death with 1-point improvement in AUA Symptom Score, and in storage and voiding subscales
A study tested a less aggressive chemoradiation protocol in patients with muscle-invasive bladder cancer (MIBC) unfit for surgery due to older age or comorbidities.
Surveillance plays a major role in the management of men with cancer clinically confined to the testis.
Non-English-speaking patient callers to hospital are less likely to be provided with next steps to access cancer care
Report highlights advances such as approval of 14 new anticancer therapeutics, expansion of use of 12 previously approved therapeutics
High-grade vesicoureteral reflux is crucial risk factor for recurrent febrile urinary tract infections in children
Less than 30% of patients report comparing drug costs before selecting a Medicare Part D plan.
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.